Cerebrospinal fluid rhinorrhea

Summary

Cerebrospinal fluid rhinorrhea (MONDO:0020773) is a disease. A subtype of cerebrospinal fluid leak — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	cerebrospinal fluid rhinorrhea
Mondo ID	MONDO:0020773
MeSH	D002559
NCIT	C84627
SNOMED CT	85638002
UMLS	C0007815
MedGen	3331
Is cancer (heuristic)	no

Also known as: cerebrospinal fluid rhinorrhea · Cerebrospinal Fluid Rhinorrhea, post Traumatic · Cerebrospinal Fluid Rhinorrhea, post-Traumatic · Cerebrospinal Fluid Rhinorrhea, Spontaneous · Cerebrospinal Fluid Rhinorrhea, Traumatic · Cerebrospinal Fluid Rhinorrheas · Cerebrospinal fluid rhinorrhoea · Cerebrospinal Rhinorrhea · Cerebrospinal rhinorrhea · Cerebrospinal Rhinorrheas · CSF - Cerebrospinal rhinorrhea · CSF Rhinorrhea · CSF Rhinorrheas · CSF rhinorrhoea · post Traumatic Cerebrospinal Fluid Rhinorrhea · post Traumatic Rhinorrhea, Cerebrospinal Fluid · post-Traumatic Cerebrospinal Fluid Rhinorrhea · post-Traumatic Rhinorrhea, Cerebrospinal Fluid · Rhinorrhea, Cerebrospinal · Rhinorrhea, Cerebrospinal Fluid (+14 more)

Data availability: 1 HPO phenotype.

Disease family

This is a subtype of cerebrospinal fluid leak. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › nervous system disorder › central nervous system disorder › cerebrospinal fluid leak › cerebrospinal fluid rhinorrhea

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.